← Back to Clinical Trials
Recruiting NCT07021183

NCT07021183 The PSP Sleep Course: An Online Sleep Intervention for Public Safety Personnel With Self-reported Sleep Difficulties.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07021183
Status Recruiting
Phase
Sponsor University of Regina
Condition Insomnia
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2025-03-06
Primary Completion 2028-03-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Sleep Course

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2025-03-06 with a primary completion date of 2028-03-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study evaluates an internet-delivered cognitive behavioural therapy for insomnia (ICBTi) intervention, known as the PSP Sleep Course, adapted for public safety personnel (PSP) experiencing sleep difficulties. The study seeks to replicate prior results from an Australian version of the Sleep Course assessing its effectiveness and acceptability when offered to Canadian PSP.

Eligibility Criteria

Inclusion Criteria: * 18 years of age or older * Canada resident * Trainee, staff, or retired public safety personnel (PSP) * Willingness to learn information and skills to manage sleep difficulties * Have internet access * Consent to the PSP Sleep Course Exclusion Criteria: * Current severe medical or psychiatric disorder (e.g. current and recent mania or psychosis, recent hospitalization for mental health concerns, actively suicidal, medical condition client thinks will interfere with treatment, severe substance use) * Unable to read and understand English. (All content is provided in English and staff is English speaking; pending findings of the research PSPNET will explore translating the course into French)

Contact & Investigator

Central Contact

Heather D Hadjistavropoulos, PhD

✉ heather.hadjistavropoulos@uregina.ca

📞 306-585-5133

Principal Investigator

Heather D Hadjistavropoulos, PhD

PRINCIPAL INVESTIGATOR

University of Regina

Frequently Asked Questions

Who can join the NCT07021183 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Insomnia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07021183 currently recruiting?

Yes, NCT07021183 is actively recruiting participants. Contact the research team at heather.hadjistavropoulos@uregina.ca for enrollment information.

Where is the NCT07021183 trial being conducted?

This trial is being conducted at Regina, Canada.

Who is sponsoring the NCT07021183 clinical trial?

NCT07021183 is sponsored by University of Regina. The principal investigator is Heather D Hadjistavropoulos, PhD at University of Regina. The trial plans to enroll 60 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology